KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Guardant Health (GH) EPS (Basic): 2017-2025

Historic EPS (Basic) for Guardant Health (GH) over the last 8 years, with Sep 2025 value amounting to -$0.74.

  • Guardant Health's EPS (Basic) rose 15.91% to -$0.74 in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.21, marking a year-over-year increase of 25.00%. This contributed to the annual value of -$3.56 for FY2024, which is 16.82% up from last year.
  • Per Guardant Health's latest filing, its EPS (Basic) stood at -$0.74 for Q3 2025, which was up 7.50% from -$0.80 recorded in Q2 2025.
  • Guardant Health's 5-year EPS (Basic) high stood at -$0.67 for Q2 2023, and its period low was -$2.25 during Q2 2022.
  • Moreover, its 3-year median value for EPS (Basic) was -$0.84 (2024), whereas its average is -$0.93.
  • Its EPS (Basic) has fluctuated over the past 5 years, first crashed by 275.86% in 2021, then spiked by 70.22% in 2023.
  • Quarterly analysis of 5 years shows Guardant Health's EPS (Basic) stood at -$0.89 in 2021, then slumped by 53.93% to -$1.37 in 2022, then fell by 18.25% to -$1.62 in 2023, then soared by 44.44% to -$0.90 in 2024, then rose by 15.91% to -$0.74 in 2025.
  • Its EPS (Basic) stands at -$0.74 for Q3 2025, versus -$0.80 for Q2 2025 and -$0.77 for Q1 2025.